RYBP Inhibits Progression and Metastasis of Lung Cancer by Suppressing EGFR Signaling and Epithelial-Mesenchymal Transition

RYBP Inhibits Progression and Metastasis of Lung Cancer by Suppressing EGFR Signaling and Epithelial-Mesenchymal Transition

Lung cancer (LC) is a common lethal malignancy with rapid progression and metastasis, and Ring1 and YY1 binding protein (RYBP) has been shown to suppress cell growth in human cancers. This study aimed to investigate the role of RYBP in LC progression and metastasis. In this study, a total of 149 LC...

Full description

Bibliographic Details
Main Authors:	Xiaoxiao Dinglin, Lin Ding, Qingjian Li, Yuanbin Liu, Jiexia Zhang, Herui Yao
Format:	Article
Language:	English
Published:	Elsevier 2017-04-01
Series:	Translational Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1936523316301735

Similar Items

The Depside Derivative Pericodepside Inhibits Cancer Cell Metastasis and Proliferation by Suppressing Epithelial–Mesenchymal Transition
by: Rui Zhou, et al.
Published: (2024-02-01)

SIRT1 Suppresses the Epithelial-to-Mesenchymal Transition in Cancer Metastasis and Organ Fibrosis
by: Simic, Petra, et al.
Published: (2014)

Epithelial–mesenchymal transition inhibition by metformin reduces melanoma lung metastasis in a murine model
by: Emerson Soares Veloso, et al.
Published: (2022-10-01)

Tilapia (Oreochromis niloticus) oligopeptide TBP-1 inhibits hepatocellular carcinoma metastasis by suppressing inflammation and epithelial-mesenchymal transition
by: Haiyan Zheng, et al.
Published: (2024-02-01)

Context Dependency of Epithelial-to-Mesenchymal Transition for Metastasis
by: Tatiana Revenco, et al.
Published: (2019-11-01)

Hypoxia activated EGFR signaling induces epithelial to mesenchymal transition (EMT)
by: Misra, Ashish, et al.
Published: (2013)

Epithelial-to-Mesenchymal Transition in Metastasis: Focus on Laryngeal Carcinoma
by: Anastasios Goulioumis, et al.
Published: (2022-09-01)

Bergamottin Suppresses Metastasis of Lung Cancer Cells through Abrogation of Diverse Oncogenic Signaling Cascades and Epithelial-to-Mesenchymal Transition
by: Jeong-Hyeon Ko, et al.
Published: (2018-07-01)

TWIST1 a new determinant of epithelial to mesenchymal transition in EGFR mutated lung adenocarcinoma.
by: Karine Pallier, et al.
Published: (2012-01-01)

Long non-coding RNA AOC4P suppresses epithelial ovarian cancer metastasis by regulating epithelial-mesenchymal transition
by: Xiaojing Lin, et al.
Published: (2020-04-01)

Retraction Notice to: MicroRNA-140 Inhibits the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer
by: Jiazhi Li, et al.
Published: (2022-12-01)

Ovalitenone Inhibits the Migration of Lung Cancer Cells via the Suppression of AKT/mTOR and Epithelial-to-Mesenchymal Transition
by: Kittipong Sanookpan, et al.
Published: (2021-01-01)

Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis
by: Saima Usman, et al.
Published: (2021-10-01)

Editorial: Molecular mechanisms of epithelial-mesenchymal transition in cancer metastasis
by: Amr Amin, et al.
Published: (2022-12-01)

Pristimerin Suppresses Trophoblast Cell Epithelial–Mesenchymal Transition via miR-542-5p/EGFR Axis
by: Shu C, et al.
Published: (2020-11-01)

DCBLD2 Mediates Epithelial-Mesenchymal Transition-Induced Metastasis by Cisplatin in Lung Adenocarcinoma
by: Xiaosu Chen, et al.
Published: (2021-03-01)

Expression of Concern: Schisandrin B Attenuates Cancer Invasion and Metastasis Via Inhibiting Epithelial-Mesenchymal Transition.
by: PLOS One Editors
Published: (2022-01-01)

Expression of Concern: Schisandrin B Attenuates Cancer Invasion and Metastasis Via Inhibiting Epithelial-Mesenchymal Transition
Published: (2022-01-01)

Juglone Inhibits Tumor Metastasis by Regulating Stemness Characteristics and the Epithelial-to-Mesenchymal Transition in Cancer Cells both in Vitro and in Vivo
by: Chendan Zou, et al.
Published: (2023-02-01)

SPATA2 suppresses epithelial‐mesenchymal transition to inhibit metastasis and radiotherapy sensitivity in non–small cell lung cancer via impairing DVL1/β‐catenin signaling
by: Hongbo Ji, et al.
Published: (2023-04-01)

HMGA2 promotes cancer metastasis by regulating epithelial–mesenchymal transition
by: Qing Ma, et al.
Published: (2024-02-01)

The Epithelial-to-Mesenchymal Transition (EMT) in the Development and Metastasis of Malignant Pleural Mesothelioma
by: Valeria Ramundo, et al.
Published: (2021-11-01)

Metabolic reprogram associated with epithelial-mesenchymal transition in tumor progression and metastasis
by: Yifan Wang, et al.
Published: (2020-06-01)

Regulation of snail in epithelial-mesenchymal transition and breast cancer progression and metastasis
by: Binhua P. Zhou
Published: (2017-03-01)

Mechanoregulation of angiopoietin-like 4 in epithelial-mesenchymal transition and cancer metastasis
by: Liao, Zehuan
Published: (2024)

The E3 ligase NEURL3 suppresses epithelial-mesenchymal transition and metastasis in nasopharyngeal carcinoma by promoting vimentin degradation
by: Shi-Qing Zhou, et al.
Published: (2024-01-01)

miR-136 Targets MIEN1 and Involves the Metastasis of Colon Cancer by Suppressing Epithelial-to-Mesenchymal Transition [Retraction]
by: Ren H, et al.
Published: (2024-02-01)

Rho GTPase-activating protein 35 suppresses gastric cancer metastasis by regulating cytoskeleton reorganization and epithelial-to-mesenchymal transition
by: Yi Sun, et al.
Published: (2022-06-01)

DCLK1 Drives EGFR-TKI-Acquired Resistance in Lung Adenocarcinoma by Remodeling the Epithelial–Mesenchymal Transition Status
by: Rui Yan, et al.
Published: (2023-05-01)

SCL/TAL1 cooperates with Polycomb RYBP-PRC1 to suppress alternative lineages in blood-fated cells
by: Chagraoui, H, et al.
Published: (2018)

CTI-2 Inhibits Metastasis and Epithelial-Mesenchymal Transition of Breast Cancer Cells by Modulating MAPK Signaling Pathway
by: Junfeng Ke, et al.
Published: (2021-11-01)

PGC1α Loss Promotes Lung Cancer Metastasis through Epithelial-Mesenchymal Transition
by: Taek-In Oh, et al.
Published: (2021-04-01)

Berberine Promotes Mouse Breast Cancer Metastasis to Lung via Inducing Epithelial–mesenchymal Transition
by: YUAN Zhiying, et al.
Published: (2023-08-01)

DNAJA4 suppresses epithelial-mesenchymal transition and metastasis in nasopharyngeal carcinoma via PSMD2-mediated MYH9 degradation
by: Qun Zhang, et al.
Published: (2023-10-01)

Role of microRNA/Epithelial-to-Mesenchymal Transition Axis in the Metastasis of Bladder Cancer
by: Milad Ashrafizadeh, et al.
Published: (2020-08-01)

Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis
by: Arpita Datta, et al.
Published: (2021-04-01)

Pancreatic RECK inactivation promotes cancer formation, epithelial-mesenchymal transition, and metastasis
by: Tomonori Masuda, et al.
Published: (2023-09-01)

PTK2 promotes uveal melanoma metastasis by activating epithelial‐to‐mesenchymal transition
by: Pu Luo, et al.
Published: (2023-09-01)

Roles of Dietary Phytoestrogens on the Regulation of Epithelial-Mesenchymal Transition in Diverse Cancer Metastasis
by: Geum-A. Lee, et al.
Published: (2016-05-01)

Network motifs and hypermotifs in TGFβ-induced epithelial to mesenchymal transition and metastasis
by: Gottumukkala Sai Bhavani, et al.
Published: (2023-03-01)